title: After local therapy for esophageal cancer, should we continue to survey patients and, if so, why and how?
authors.forename: Jaffer A
authors.initials: JA
authors.lastname: Ajani
mesh_terms: D003362:Cost-Benefit Analysis; D019468:Disease Management; D004938:Esophageal Neoplasms / Q000473:pathology* / Q000628:therapy*; D005500:Follow-Up Studies; D017048:Health Care Costs; D006801:Humans